Item 7.01 Regulation FD Disclosure.

On December 2, 2022, Amgen Inc. ("Amgen") issued an announcement pursuant to Rule 2.12 of the Irish Takeover Panel Act, 1997, Takeover Rules 2022. A copy of the announcement is filed as Exhibit 99.1 hereto and is incorporated by reference into this Item 7.01.

The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor will such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit     Description

99.1          Announcement, dated December 2, 2022.

104         Cover Page Interactive Data File (the cover page XBRL tags are
            embedded within the Inline XBRL document).



                                      -1-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses